These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22172011)

  • 1. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
    Khuntawee W; Rungrotmongkol T; Hannongbua S
    J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex.
    Zhang J; Zhang L; Xu Y; Jiang S; Shao Y
    PLoS One; 2018; 13(5):e0196651. PubMed ID: 29715320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
    Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
    Lu H; Chang DJ; Baratte B; Meijer L; Schulze-Gahmen U
    J Med Chem; 2005 Feb; 48(3):737-43. PubMed ID: 15689157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for CDK6 activation by a virus-encoded cyclin.
    Schulze-Gahmen U; Kim SH
    Nat Struct Biol; 2002 Mar; 9(3):177-81. PubMed ID: 11828325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors.
    Sims PA; Wong CF; McCammon JA
    J Med Chem; 2003 Jul; 46(15):3314-25. PubMed ID: 12852762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing CDK4/6-p16(INK4a) interface. Computational alanine scanning of a peptide bound to CDK6 protein.
    Villacañas O; Rubio-Martinez J
    Proteins; 2006 Jun; 63(4):797-810. PubMed ID: 16508961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced state transition barrier of CDK6 from open to closed state induced by Thr177 phosphorylation and its implication in binding modes of inhibitors.
    He H; Xu J; Xie W; Guo QL; Jiang FL; Liu Y
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):501-512. PubMed ID: 29108955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.
    Luo X; Zhao Y; Tang P; Du X; Li F; Wang Q; Li R; He J
    Mol Divers; 2021 Feb; 25(1):367-382. PubMed ID: 32770459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition.
    Lu H; Schulze-Gahmen U
    J Med Chem; 2006 Jun; 49(13):3826-31. PubMed ID: 16789739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6.
    Yousuf M; Shamsi A; Khan P; Shahbaaz M; AlAjmi MF; Hussain A; Hassan GM; Islam A; Rizwanul Haque QM; Hassan MI
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol.
    de Azevedo WF; Canduri F; da Silveira NJ
    Biochem Biophys Res Commun; 2002 Apr; 293(1):566-71. PubMed ID: 12054639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.
    Zaharevitz DW; Gussio R; Leost M; Senderowicz AM; Lahusen T; Kunick C; Meijer L; Sausville EA
    Cancer Res; 1999 Jun; 59(11):2566-9. PubMed ID: 10363974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRID and docking analyses reveal a molecular basis for flavonoid inhibition of Src family kinase activity.
    Wright B; Watson KA; McGuffin LJ; Lovegrove JA; Gibbins JM
    J Nutr Biochem; 2015 Nov; 26(11):1156-65. PubMed ID: 26140983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the skeleton structure of flavanone and flavonoid on interaction with transferrin.
    Zhang XF; Han RM; Sun XR; Li GY; Yang QF; Li Q; Gai W; Zhang M; Chen L; Yang G; Tang YL
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6677-81. PubMed ID: 24239187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavopiridol binds to duplex DNA.
    Bible KC; Bible RH; Kottke TJ; Svingen PA; Xu K; Pang YP; Hajdu E; Kaufmann SH
    Cancer Res; 2000 May; 60(9):2419-28. PubMed ID: 10811119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
    Kaiser A; Nishi K; Gorin FA; Walsh DA; Bradbury EM; Schnier JB
    Arch Biochem Biophys; 2001 Feb; 386(2):179-87. PubMed ID: 11368340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.